ANGN
Price:
$1
Market Cap:
$30.11M
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute organ injuries, such as delayed graft function; ROCK2 inhibitors programs for fibrotic diseases; and CYP11B2 inhibitor program. The company was incorporated in 1998 and is based in Uniondale, New York.[Read more]
Industry
Biotechnology
IPO Date
2021-02-05
Stock Exchange
NASDAQ
Ticker
ANGN
According to Angion Biomedica Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -0.10. This represents a change of -78.09% compared to the average of -0.45 of the last 4 quarters.
The mean historical PE Ratio of Angion Biomedica Corp. over the last ten years is 194.71. The current -0.10 PE Ratio has changed -105.08% with respect to the historical average. Over the past ten years (40 quarters), ANGN's PE Ratio was at its highest in in the March 2013 quarter at 1.39K. The PE Ratio was at its lowest in in the June 2014 quarter at -274.29.
Average
194.71
Median
-1.52
Minimum
-13.06
Maximum
935.99
Discovering the peaks and valleys of Angion Biomedica Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 935.99
Minimum Annual Increase = -102.87%
Minimum Annual PE Ratio = -13.06
Year | PE Ratio | Change |
---|---|---|
2022 | -0.44 | -71.26% |
2021 | -1.52 | -75.28% |
2020 | -6.16 | -9.22% |
2019 | -6.79 | -48.01% |
2018 | -13.06 | -102.87% |
2013 | 454.94 | -51.39% |
The current PE Ratio of Angion Biomedica Corp. (ANGN) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-2.71
5-year avg
-5.59
10-year avg
194.71
Angion Biomedica Corp.’s PE Ratio is less than eFFECTOR Therapeutics, Inc. (-0.00), greater than Landos Biopharma, Inc. (-5.74), greater than Apexigen, Inc. (-0.36), less than Navidea Biopharmaceuticals, Inc. (0.03), less than Oncorus, Inc. (-0.04), greater than Apollomics, Inc. (-0.22), greater than Sigilon Therapeutics, Inc. (-1.90), greater than Pyxis Oncology, Inc. (-3.58), greater than Zura Bio Limited (-9.00), less than Altamira Therapeutics Ltd. (-0.03), greater than Elevation Oncology, Inc. (-0.93), less than ZyVersa Therapeutics, Inc. (-0.10), greater than Palisade Bio, Inc. (-0.31), greater than Unicycive Therapeutics, Inc. (-0.46), greater than Immix Biopharma, Inc. (-2.98),
Company | PE Ratio | Market cap |
---|---|---|
-0.00 | $188.18K | |
-5.74 | $71.68M | |
-0.36 | $9.57M | |
0.03 | $100.08K | |
-0.04 | $3.14M | |
-0.22 | $14.97M | |
-1.90 | $56.22M | |
-3.58 | $206.30M | |
-9.00 | $230.86M | |
-0.03 | $2.04M | |
-0.93 | $36.94M | |
-0.10 | $2.70M | |
-0.31 | $4.25M | |
-0.46 | $33.41M | |
-2.98 | $54.08M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Angion Biomedica Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Angion Biomedica Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Angion Biomedica Corp.'s PE Ratio?
How is the PE Ratio calculated for Angion Biomedica Corp. (ANGN)?
What is the highest PE Ratio for Angion Biomedica Corp. (ANGN)?
What is the 3-year average PE Ratio for Angion Biomedica Corp. (ANGN)?
What is the 5-year average PE Ratio for Angion Biomedica Corp. (ANGN)?
How does the current PE Ratio for Angion Biomedica Corp. (ANGN) compare to its historical average?